Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.
J M van Berge HenegouwenH van der WijngaartL J ZeverijnL R HoesM MeertensA D R HuitemaL A DevrieseM LabotsH M W VerheulE E VoestAndré B P van KuilenburgPublished in: Cancer chemotherapy and pharmacology (2022)
Clinical trial identification: NCT02925234.